Clin2
NCT07749742Likely a fitRecruiting

Study of MI226 injection for belly fat

Abdominal Fat

This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
52 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old.
  • Your body mass index (BMI) is between 19 and 37.
  • You have enough belly fat that the doctor can see and feel it.
  • You are willing to use birth control and not donate sperm or eggs for 3 months after the last dose.
  • You agree to follow the study rules and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07648225Not yet recruiting· Phase 3
UBT251 Injection Study for Weight Loss

This study tests a new injection (UBT251) to help people lose weight and improve weight-related health problems. You may qualify if you're overweight or obese and have tried diet and exercise for at least 3 months without much success.

Beijing
NCT07608770Recruiting· Phase 2
CBL-514 injection to reduce belly fat

This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.

South Yarra, Victoria
NCT07140939Not yet recruiting· Phase 3
Study of CBL-514 injection for belly fat reduction

This trial tests an injection called CBL-514 to reduce stubborn belly fat in people who are at a healthy weight but have moderate to severe abdominal fat. It may be an option if you've kept a stable lifestyle and are looking for a non-surgical approach.

Encinitas, California
NCT07608757Not yet recruiting· Phase 2
Injectable treatment to reduce belly fat in adults

This study tests a new injectable medication (CBL-514) designed to reduce stubborn fat under the skin in the abdominal area. Researchers will evaluate how well it works, its safety, and how patients tolerate it.

South Yarra, Victoria
NCT07526974Not yet recruiting· Phase 3
CBL-514 injection for reducing belly fat

This study tests whether CBL-514, an injectable medication, can safely reduce unwanted fat deposits under the skin in the abdomen. If it works, it could offer people a non-surgical option to improve the appearance of belly fat they're unhappy with.

Encinitas, California
NCT07224399Recruiting· Phase 1
Testing a new injection for weight loss in obesity

This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.

Baltimore, Maryland

Hear when a new Abdominal Fat trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.